Literature DB >> 3333274

Cytogenetic effects induced by alkylated guanine in mammalian cells.

S Bonatti1, M De Ferrari, V Pisano, A Abbondandolo.   

Abstract

Cytogenetic effects of O6-ethylguanine (O6EtG) were investigated in V79 Chinese hamster cells and human lymphocytes. The frequency of micronuclei and of polyploid cells was increased in a dose-dependent manner in V79 cells. Micronuclei were larger than those induced by the alkylating agent diethylsulfate, suggesting that they originated from chromosome loss rather than from chromosome breakage. Chromosome displacement was also observed and further indicated damage to the spindle. In human lymphocytes, both aneuploidy and polyploidy were induced. O6EtG did not induce either micronuclei or polyploidy in a V79 derivative, deficient in hypoxanthine-guanine phosphoribosyl transferase, suggesting that conversion of the base to a nucleotide is necessary. Preliminary data indicated that 7-ethylguanine was also able to induce aneuploidy and polyploidy in lymphocytes, although it was barely active in V79 cells. The hypothesis proposed is that alkylated nucleotides may behave as spindle poisons. As a consequence, treatment of mammalian cells with alkylating agents may induce numerical chromosome aberrations via alkylation of guanine nucleotide pools, a pathway which has not so far been proposed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3333274     DOI: 10.1093/mutage/1.2.99

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  2 in total

1.  Safety, pharmacokinetics and antiviral activity of AT-527, a novel purine nucleotide prodrug, in HCV-infected subjects with and without cirrhosis.

Authors:  Elina Berliba; Maxim Bogus; Frédéric Vanhoutte; Pieter-Jan Berghmans; Steven S Good; Adel Moussa; Keith Pietropaolo; Robert L Murphy; Xiao-Jian Zhou; Jean-Pierre Sommadossi
Journal:  Antimicrob Agents Chemother       Date:  2019-09-30       Impact factor: 5.191

2.  Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus.

Authors:  Steven S Good; Adel Moussa; Xiao-Jian Zhou; Keith Pietropaolo; Jean-Pierre Sommadossi
Journal:  PLoS One       Date:  2020-01-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.